Lenvatinib (Lenvima ) ( len-va-ti-nib )

Similar documents
Ibrutinib (Imbruvica )

Dabrafenib (Tafinlar )

Imatinib (Gleevec ) ( eye-mat-eh-nib )

Sorafenib (Nexavar ) ( sor-af-e-nib )

Midostaurin (Rydapt )

Everolimus (Afinitor )

Eltrombopag (Promacta )

For the Patient: Afatinib Other names: GIOTRIF, GILOTRIF

For the Patient: Lenvatinib Other names: LENVIMA

For the Patient: Everolimus tablets Other names: AFINITOR

For the Patient: Vemurafenib Other names: ZELBORAF

Capecitabine. Other Names: Xeloda. About This Drug. Possible Side Effects. Warnings and Precautions

ABOUT THIS MEDICATION

ORAL CHEMOTHERAPY EDUCATION

ORAL CHEMOTHERAPY EDUCATION

Trastuzumab and Lapatinib

For the Patient: Ponatinib Other names: ICLUSIG

ORAL CHEMOTHERAPY EDUCATION

For the Patient: Olaparib tablets Other names: LYNPARZA

Sorafenib (so-ra-fe-nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth.

Open to the possibility of a multiple myeloma treatment that works in cells in your body at the DNA level

ORAL CHEMOTHERAPY EDUCATION

Sunitinib. Other Names: Sutent. About This Drug. Possible Side Effects. Warnings and Precautions

ORAL CHEMOTHERAPY EDUCATION

What are some things I need to know or do while I take

For the Patient: Cobimetinib tablets Other names: COTELLIC

ORAL CHEMOTHERAPY EDUCATION

(sunitinib malate) for Kidney Cancer

Inlyta (axitinib) for Kidney Cancer

YOUR CABOMETYX HANDBOOK

ORAL CHEMOTHERAPY EDUCATION

Treatment Journal. Therapy Tracker TREATMENT JOURNAL

For the Patient: Fludarabine injection Other names: FLUDARA

ORAL CHEMOTHERAPY EDUCATION

ORAL CHEMOTHERAPY EDUCATION

Capecitabine and Lapatinib

Nivolumab. Other Names: Opdivo. About this Drug. Possible Side Effects (More Common) Warnings and Precautions

For the Patient: Lenalidomide Other names: REVLIMID

It is used to treat or prevent upset stomach and throwing up. What do I need to tell my doctor BEFORE I take this drug?

For the Patient: UGINETEV Other Names: Treatment of advanced neuroendocrine tumours of gastrointestinal origin (Non-Functional) using Everolimus

Regorafenib (Stivarga )

Oral Systemic Therapy

ORAL CHEMOTHERAPY EDUCATION

UW MEDICINE PATIENT EDUCATION. PCV Treatment Chemotherapy for brain tumors DRAFT. PCV is a type of chemotherapy (chemo) treatment for brain

Oral Systemic Therapy

For the Patient: Trastuzumab emtansine Other names: KADCYLA

Nilotinib (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth.

For the Patient: USMAVFIPI

For the Patient: Sunitinib Other names: SUTENT

What is Capecitabine (ka-pe-site-a-been) and how does it work?

What is the most important information I should know about bortezomib? What should I discuss with my healthcare provider before receiving bortezomib?

Valsartan and Hydrochlorothiazide

Pazopanib (Votrient )

It may be g iven to you for other reasons. Talk with the doctor. What do I need to tell my doctor BEFORE I take this drug?

In-Patient Radioactive Iodine ( 131 I) Treatment

For the Patient: Bendamustine Other names: TREANDA

For the Patient: USMAVTRA Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Trametinib

What do I need to tell my doctor BEFORE I take this drug?

Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop.

It may be g iven to you for other reasons. Talk with the doctor. What do I need to tell my doctor BEFORE I take this drug?

For the Patient: CAP. Capecitabine. Uses:

For the Patient: Rituximab injection Other names: RITUXAN

ORAL CHEMOTHERAPY EDUCATION

For the Patient: Paclitaxel Other names: TAXOL

ORAL CHEMOTHERAPY EDUCATION

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers

ORAL CHEMOTHERAPY EDUCATION

ORAL CHEMOTHERAPY EDUCATION

ORAL CHEMOTHERAPY EDUCATION

For the Patient: LUAVPG (Carboplatin Option)

ORAL CHEMOTHERAPY EDUCATION

For the Patient: Eribulin Other names: HALAVEN

Your guide to taking LENVIMA for hepatocellular carcinoma (HCC), a type of liver cancer

For the Patient: Amsacrine Other names: AMSA PD

For the Patient: LUAVPEM

For the Patient: Mitoxantrone Other names:

ORAL CHEMOTHERAPY EDUCATION

ORAL CHEMOTHERAPY EDUCATION

Docetaxel (Taxotere )

It is used to lower blood sugar in patients with high blood sugar (diabetes). What do I need to tell my doctor BEFORE I take this drug?

It is used to treat breast cancer in women after chang e of life. It may be g iven to you for other reasons. Talk with the doctor.

ORAL CHEMOTHERAPY EDUCATION

For males: use effective birth control during your treatment with INLYTA. Talk to your doctor about birth control methods.

ORAL CHEMOTHERAPY EDUCATION

It may be g iven to your child for other reasons. Talk with the doctor.

What do I need to tell my doctor BEFORE I take this drug?

What is Abemaciclib (ABEM-a-si-clib) and how does it work?

You can only get this drug through the Natpara REMS Program.

AN ADVANCEMENT FOR POSTMENOPAUSAL WOMEN WITH ER+/HER2- METASTATIC BREAST CANCER.

Amlodipine and Celecoxib

For the Patient: GIAVPANI Other Names: Palliative third line treatment of metastatic cancer of the colon or rectum using Panitumumab

What is Neratinib (ne-ra-ti-nib) and how does it work?

Trastuzumab (Herceptin )

What do I need to tell my doctor BEFORE I take this drug? If you have an allerg y to ofatumumab or any other part of this drug.

ORAL CHEMOTHERAPY EDUCATION

For the Patient: PROTOCOL SMAVTMZ Other Names: Palliative Therapy for Malignant Melanoma with Brain Metastases Using Temozolomide

For the Patient: Alemtuzumab SC injection Other names: MABCAMPATH, CAMPATH

For the Patient: Doxorubicin pegylated liposomal Other names: CAELYX, DOXIL, PLD

MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII)

Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor

Transcription:

Lenvatinib (Lenvima ) ( len-va-ti-nib ) How drug is given: By mouth Purpose: To treat thyroid cancer or other cancers How to take this drug This medicine can be taken with or without food. Take each dose at the same time each day. If a dose is missed, take it as soon as possible. If it cannot be taken within 12 hours, skip that dose and take the next dose at the usual time. Do not take a double dose. Storage Store this medicine at room temperature, away from heat and moisture. Keep this medicine in its original container, out of the reach of children and pets. If you have unused oral chemotherapy pills (tablets or capsules), please return to the pharmacy where the prescription was filled. Do not flush down the toilet, dump in the sink, or throw away in the trash. Things that may occur may occur during treatment 1. Your blood pressure may go up. If this happens, you may be given medication to help with this. If you have headaches or dizziness, tell your cancer care team right away. 2. Some patients may feel very tired, also known as fatigue. You may need to rest or take naps more often. Mild to moderate exercise can also help you maintain your energy. In some cases, fatigue may be a sign of hypothyroidism. This is a condition in which your thyroid gland does not produce enough thyroid hormone. If you feel fatigued and have symptoms such as an unusual sensitivity to cold or modest weight gain, talk with your cancer care team. 3. Loose stools or diarrhea may occur within a few days after the drug is started. You may take loperamide (Imodium A-D ) to help control diarrhea. You can buy this at most drug stores. Be Last Revised 06/2015 Patient and Family Education Committee

Lenvatinib Page 2 of 3 sure to also drink more fluids (water, juice, sports drinks). If these do not help within 24 hours, call your cancer care team. 4. Your body may not be able to get rid of extra fluid. This is called edema. You may notice some swelling in your arms or legs 5. You may have a fast or unusual heartbeat. If you feel any changes in your heartbeat, tell your cancer care team right away. 6. You may be at increased risk for bleeding. Call your doctor if you: have blood in your urine or stool feel dizzy or faint have a nosebleed that does not stop after 10-15 minutes If you have a nosebleed, sit with your head tipped slightly forward. Use your thumb and forefingerto lightly pinch the soft part of your nose for a full 10 minutes. Apply ice to the bridge of the nose. 7. You may feel pain or weakness in your joints or muscles. If this bothers you, ask your cancer care team what type of drugs you may use to help with this pain. 8. The palms of your hands or the soles of your feet may become red and painful. This is called hand-foot syndrome. Tingling and peeling of the skin may occur. Avoid tight fitting shoes. Use thick (moisturizing) creams on hands and feet. 9. You may get a headache. Please talk to your cancer care team about what you can take for this. 10. Mild constipation may occur after treatment begins. Please increase your fluid intake and increase fiber in your diet by eating fresh fruits and vegetables. A daily stool softener, such as docusate (Colace ), and/or laxatives, such as senna (Senakot ), may be helpful. If these do not help within 48 hours, tell your cancer care team. Do not use bulk forming laxatives such as Metamucil without first talking with your cancer care team. 11. Skin changes, such as dryness or a rash on your body, may occur. Ask your cancer care team what lotions or creams you may use. 12. If you develop a new or worsening cough or shortness of breath, tell your cancer care team. 13. You may have hoarseness or other changes in your voice. 14. Loss of appetite may occur. This may lead to weight loss. Talk to your cancer care team if you have questions or concerns. 15. Mild to moderate nausea, vomiting, and loss of appetite may occur. You may be given medicine to help with this. Last Revised 06/2015 Patient and Family Education Committee

Lenvatinib Page 3 of 3 16. You may get mouth pain or sores. You may have a burning feeling and redness inside the mouth or on the lips. Mouth rinses may be ordered by your doctor. Check with your doctor before having any dental work done. 17. In rare cases, a special problem with nerves called reversible posterior leukoencephalopathy syndrome (RPLS) may occur. Patients may have symptoms such as: headache, nausea, feeling sleepy or confused, a change in eyesight, seizures, or other problems. This can happen 16 hours to one year after starting Lenvatinib. Call your cancer care team is you have any of these symptoms. Early treatment can help, but delayed treatment can result in more permanent damage. 18. Fertility and Related Precautions: If you are having sex, it is very important to use birth control during therapy and for at least 2 weeks after last dose, because this drug may be harmful to an unborn baby. Women should not breastfeed while taking this drug. Men can become sterile and may want to think about sperm banking prior to chemotherapy. For women, your period (menstrual cycle) may not be regular for a while or may stop completely and you may not be able to get pregnant. If you are concerned about any of this, please talk with your cancer care team The above information includes some, but not necessarily all, of the possible side effects of this medication. The side effects listed in this teaching sheet may not be the same ones you experience. Your side effects may be different depending on how often you receive treatment (your schedule) and how much you receive each time (your dosage). Side effects may also vary if you are taking other medications. Please speak with your doctor or nurse if you have questions about possible side effects you may experience. This document should not take the place of conversations with members of your health care team. If you experience any significant change in your health during or after treatment, contact a member of your health care team right away. Managing your oral chemotherapy schedule at home can be challenging. To help you with this, consider using tools to help you keep track of your schedule and any side effects you may have. You can find these tools online at www.dana-farber.org/oralchemodiary. THIS SPACE RESERVED FOR WRITTEN COMMENTS OR NOTES FOR THE PATIENT AND FAMILY: Last Revised 06/2015 Patient and Family Education Committee

Oral Chemotherapy Fact Sheet Oral chemotherapy medicines are given by mouth in the form of capsules, tablets, or liquid. These safety tips will help you understand what to do when you are taking oral chemotherapy. Please note: If you are on a clinical trial, you may be given special instructions. How to take this drug Swallow each tablet or capsule whole. Do not break, crush, or chew. Prepare your drug away from food and food prep areas. If you miss a dose, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double the dose. If you are on a clinical trial, you will be given special instructions if you miss a dose. If you are unable to swallow the pill, speak with your nurse or pharmacist about other ways to take your medication. If you vomit or throw up your medication, call your physician for further instructions. Wash your hands after taking the medication. Avoid handling crushed or broken pills (tablets or capsules). Storage Most oral chemotherapy medicine is stored at room temperature, away from excess heat and moisture. You will be told if the medication you are taking needs special storage or handling. Keep this medicine in its original container, in a safe place, away from other family medications. All medications need to be kept out of the reach of children and pets. Last Revised 3/2015 Patient Education Committee

Oral Chemotherapy Fact Sheet Page 2 of 3 Disposal If you have unused oral chemotherapy pills (tablets or capsules), please return them to the pharmacy where the prescription was filled. Do not flush down the toilet, dump in the sink, or throw away in the trash. Safe handling of body waste in the home after chemotherapy Chemotherapy stays in the body for hours or even days, and is found in vomit, urine, stool, and sweat (body wastes). Special care must be taken to prevent the patient s body waste from coming into accidental contact with the patient or caregiver. Body wastes Patient and caregiver: You can use the toilet (septic tank or city sewage) as usual. There is no research to support double flushing to prevent accidental contact (although this may be suggested for certain medications). Ask your doctor or nurse what they suggest for your medication. Wash your hands well with soap and water after using the toilet. If urine, vomit, or stool gets on your body, wash with soap and water. Always wear gloves when cleaning equipment or disposing waste from a urinal or commode. Pregnant caregivers should not handle patient body waste. It is safe for family and friends to use the same toilet, as long as all body waste is cleaned from the toilet. To absorb urine or stool, use a disposable, plastic-backed pad, diaper, or sheet. Change it immediately when soiled. Then wash skin with soap and water. If you have an ostomy, you or your caregiver may want to wear gloves when emptying or changing appliances. Laundry Always wear disposable gloves when handling sheets or clothes that have been soiled with body waste. Soiled items should be kept and washed separately from the other laundry. Oral chemotherapy is a serious drug that requires extra caution. If you have questions or concerns about your oral chemotherapy, do not hesitate to call your clinician. For more tips, tools and short videos to help you manage oral chemotherapy visit our web page at http://www.dana-farber.org/oralchemo Last Revised 3/2015 Patient Education Committee

Oral Chemotherapy Fact Sheet Page 3 of 3 The materials included on this page are for informational purposes only. The content is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. THIS SPACE RESERVED FOR WRITTEN COMMENTS OR NOTES FOR THE PATIENT AND FAMILY: Last Revised 3/2015 Patient Education Committee